- Home
- Apac Flow Cytometry Market
APAC Flow Cytometry Market - Industry Trends and Forecast to 2029
- Published Date: September, 2022 | Report ID: CLS-548 | No of pages: 252 | Format:
The Asia-Pacific flow cytometry market is projected to register a substantial CAGR of 10.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation:
Asia-Pacific Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific), Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of Asia-Pacific flow cytometry are:
Rising prevalence of chronic diseases
Increasing application of cytometry instruments
Market Players:
Some of the major players operating in the Asia-Pacific flow cytometry market are:
Thermo Fisher Scientific Inc.
BD
Agilent Technologies, Inc.
Luminex Corporation (now subsidiary of DiaSorin S.p.A.)
Bio-Rad Laboratories, Inc.
Sysmex Corporation
II-VI Incorporated
Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
Cytek Biosciences
bioMrieux SA
Q2 Solutions (a Subsidiary of IQVIA)
Cytonome/ST, LLC
Merck KGaA
Sony Biotechnology Inc.
Cell Signaling Technology, Inc.
Enzo Biochem Inc.
Takara Bio Inc.
CellKraft Biotech Pvt. Ltd.
IKEDA SCIENTIFIC Co., Ltd.
Apogee Flow Systems Ltd.
Sartorius AG
Bay bioscience Co., Ltd.
Elabscience Biotechnology Inc.
Miltenyi Biotec
CytoBuoy b.v.
ORFLO Technologies
BioLegend, Inc.
NeoGenomics Laboratories
Nexcelom Bioscience LLC
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.3 OVERVIEW OF THE ASIA PACIFIC FLOW CYTOMETRY MARKET 38
1.4 LIMITATIONS 40
1.5 MARKETS COVERED 41
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 PRODUCT SEGMENT LIFELINE CURVE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 MARKET APPLICATION COVERAGE GRID 53
2.11 VENDOR SHARE ANALYSIS 54
2.12 SECONDARY SOURCES 55
2.13 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 60
4.1 PORTERS FIVE FORCES 61
5 MARKET OVERVIEW 62
5.1 DRIVERS 64
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES 64
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 65
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 66
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES 67
5.2 RESTRAINTS 67
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 67
5.2.2 LIMITATIONS OF FLOW CYTOMETRY 68
5.2.3 LACK OF SKILLED PROFESSIONALS 69
5.3 OPPORTUNITIES 69
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 69
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 70
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 71
5.3.4 DEVELOPING PIPELINE OF STEM CELL RESEARCH 71
5.4 CHALLENGES 72
5.4.1 DIFFICULTY IN DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 72
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 72
6 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT 74
6.1 OVERVIEW 75
6.2 REAGENTS AND CONSUMABLES 78
6.2.1 DYE 79
6.2.2 ANTIBODIES 79
6.2.3 BEADS 79
6.2.4 OTHERS 79
6.3 FLOW CYTOMETRY INSTRUMENTS 79
6.3.1 CELL ANALYZERS 81
6.3.1.1 CELL ANALYZERS, BY TYPE 81
6.3.1.1.1 IMAGING FLOW CYTOMETERS 81
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 81
6.3.1.2 CELL ANALYZERS, BY MODALITY 81
6.3.1.2.1 BENCHTOP 82
6.3.1.2.2 STANDALONE 82
6.3.2 CELL SORTERS 82
6.3.2.1 BENCHTOP 82
6.3.2.2 STANDALONE 82
6.4 ACCESSORIES 82
6.4.1 FILTERS 84
6.4.2 DETECTORS 84
6.4.3 OTHERS 84
6.5 SERVICES 84
6.6 SOFTWARE 85
7 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY 86
7.1 OVERVIEW 87
7.2 CELL-BASED FLOW CYTOMETRY 90
7.3 BEAD-BASED FLOW CYTOMETRY 90
8 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION 92
8.1 OVERVIEW 93
8.2 RESEARCH APPLICATIONS 96
8.2.1 CELL CYCLE ANALYSIS 97
8.2.2 CELL SORTING/SCREENING 97
8.2.3 CELL TRANSFECTION/VIABILITY 97
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 98
8.2.4.1 DRUG DISCOVERY 98
8.2.4.2 STEM CELL RESEARCH 98
8.2.4.3 IN VITRO TOXICITY TESTING 98
8.2.5 IMMUNOLOGY 98
8.2.6 APOPTOSIS 98
8.2.7 CELL COUNTING 98
8.2.8 OTHERS 98
8.3 CLINICAL APPLICATIONS 99
8.3.1 HAEMATOLOGY 100
8.3.2 CANCER 100
8.3.3 IMMUNODEFICIENCY DISEASES 100
8.3.4 ORGAN TRANSPLANTATION 100
8.3.5 OTHER CLINICAL APPLICATION 100
8.4 INDUSTRIAL APPLICATIONS 101
9 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY END USER 102
9.1 OVERVIEW 103
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 106
9.3 ACADEMIC & RESEARCH INSTITUTES 107
9.4 HOSPITALS 108
9.5 CLINICAL TESTING LABORATORIES 109
9.6 BLOOD BANK 110
9.7 OTHERS 111
10 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 112
10.1 OVERVIEW 113
10.2 RETAIL SALES 116
10.3 DIRECT TENDERS 117
11 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY REGION 118
11.1 ASIA-PACIFIC 119
11.1.1 JAPAN 127
11.1.2 CHINA 131
11.1.3 INDIA 135
11.1.4 SOUTH KOREA 139
11.1.5 AUSTRALIA 143
11.1.6 SINGAPORE 147
11.1.7 THAILAND 151
11.1.8 MALAYSIA 155
11.1.9 INDONESIA 159
11.1.10 PHILIPPINES 163
11.1.11 REST OS ASIA-PACIFIC 167
12 ASIA PACIFIC FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 168
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 168
13 SWOT ANALYSIS 169
14 COMPANY PROFILE 170
14.1 THERMO FISHER SCIENTIFIC INC. (2021) 170
14.1.1 COMPANY SNAPSHOT 170
14.1.2 REVENUE ANALYSIS 170
14.1.3 COMPANY SHARE ANALYSIS 171
14.1.4 PRODUCT PORTFOLIO 171
14.1.5 RECENT DEVELOPMENTS 172
14.1.5.1 ACQUISITION 172
14.2 BD (2021) 174
14.2.1 COMPANY SNAPSHOT 174
14.2.2 REVENUE ANALYSIS 174
14.2.3 COMPANY SHARE ANALYSIS 175
14.2.4 PRODUCT PORTFOLIO 175
14.2.5 RECENT DEVELOPMENT 176
14.2.5.1 COLLABORATION 176
14.3 AGILENT TECHNOLOGIES, INC. (2021) 177
14.3.1 COMPANY SNAPSHOT 177
14.3.2 REVENUE ANALYSIS 177
14.3.3 COMPANY SHARE ANALYSIS 178
14.3.4 PRODUCT PORTFOLIO 178
14.3.5 RECENT DEVELOPMENT 180
14.3.5.1 ACQUISITION 180
14.4 LUMINEX CORPORATION (NOW SUBSIDIARY OF DIASORIN S.P.A.) 181
14.4.1 COMPANY SNAPSHOT 181
14.4.2 COMPANY SHARE ANALYSIS 181
14.4.3 PRODUCT PORTFOLIO 182
14.4.4 RECENT DEVELOPMENTS 184
14.4.4.1 PRODUCT LAUNCH 184
14.5 SARTORIUS AG (2021) 185
14.5.1 COMPANY SNAPSHOT 185
14.5.2 REVENUE ANALYSIS 185
14.5.3 COMPANY SHARE ANALYSIS 186
14.5.4 PRODUCT PORTFOLIO 186
14.5.5 RECENT DEVELOPMENTS 187
14.6 BAY BIOSCIENCE CO., LTD. 188
14.6.1 COMPANY SNAPSHOT 188
14.6.2 PRODUCT PORTFOLIO 188
14.6.3 RECENT DEVELOPMENT 188
14.7 BIOMRIEUX SA (2021) 189
14.7.1 COMPANY SNAPSHOT 189
14.7.2 REVENUE ANALYSIS 189
14.7.3 PRODUCT PORTFOLIO 190
14.7.4 RECENT DEVELOPMENT 190
14.8 Q2 SOLUTION (A SUBSIDIARY OF IQVIA) 191
14.8.1 COMPANY SNAPSHOT 191
14.8.2 REVENUE ANALYSIS 191
14.8.3 SERVICE PORTFOLIO 192
14.8.4 RECENT DEVELOPMENT 192
14.9 TAKARA BIO INC. (2021) 193
14.9.1 COMPANY SNAPSHOT 193
14.9.2 REVENUE ANALYSIS 193
14.9.3 PRODUCT PORTFOLIO 194
14.9.4 RECENT DEVELOPMENTS 194
14.10 APOGEE FLOW SYSTEMS LTD. 195
14.10.1 COMPANY SNAPSHOT 195
14.10.2 PRODUCT PORTFOLIO 195
14.10.3 RECENT DEVELOPMENT 195
14.10.3.1 PRODUCT LAUNCH 195
14.11 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) (2021) 196
14.11.1 COMPANY SNAPSHOT 196
14.11.2 REVENUE ANALYSIS 196
14.11.3 PRODUCT PORTFOLIO 197
14.11.4 RECENT DEVELOPMENTS 198
14.11.4.1 ACQUISITION 198
14.11.4.2 PRODUCT LAUNCH 199
14.12 BENNUBIO INC. 200
14.12.1 COMPANY SNAPSHOT 200
14.12.2 PRODUCT PORTFOLIO 200
14.12.3 RECENT DEVELOPMENTS 200
14.13 BIOLEGEND, INC. 201
14.13.1 COMPANY SNAPSHOT 201
14.13.2 PRODUCT PORTFOLIO 201
14.13.3 RECENT DEVELOPMENT 203
14.13.3.1 ACQUISITION 203
14.14 BIO-RAD LABORATORIES, INC. (2021) 205
14.14.1 COMPANY SNAPSHOT 205
14.14.2 REVENUE ANALYSIS 205
14.14.3 PRODUCT PORTFOLIO 206
14.14.4 RECENT DEVELOPMENT 206
14.15 CELL SIGNALING TECHNOLOGY, INC. 207
14.15.1 COMPANY SNAPSHOT 207
14.15.2 PRODUCT PORTFOLIO 207
14.15.3 RECENT DEVELOPMENT 208
14.16 CELLKRAFT BIOTECH PVT. LTD 209
14.16.1 COMPANY SNAPSHOT 209
14.16.2 PRODUCT PORTFOLIO 209
14.16.3 RECENT DEVELOPMENT 210
14.17 CYTEK BIOSCIENCES (2021) 211
14.17.1 COMPANY SNAPSHOT 211
14.17.2 PRODUCT PORTFOLIO 211
14.17.3 RECENT DEVELOPMENTS 212
14.17.3.1 PRODUCT LAUNCH 212
14.17.3.2 ACQUISITION 212
14.18 CYTOBUOY B.V. 214
14.18.1 COMPANY SNAPSHOT 214
14.18.2 PRODUCT PORTFOLIO 214
14.18.3 RECENT DEVELOPMENT 214
14.19 CYTONOME/ST, LLC 215
14.19.1 COMPANY SNAPSHOT 215
14.19.2 PRODUCT PORTFOLIO 215
14.19.3 RECENT DEVELOPMENTS 215
14.20 ELABSCIENCE BIOTECHNOLOGY INC. 216
14.20.1 COMPANY SNAPSHOT 216
14.20.2 PRODUCT PORTFOLIO 216
14.20.3 RECENT DEVELOPMENT 217
14.21 ENZO BIOCHEM INC. 218
14.21.1 COMPANY SNAPSHOT 218
14.21.2 REVENUE ANALYSIS 218
14.21.3 PRODUCT PORTFOLIO 219
14.21.4 RECENT DEVELOPMENTS 219
14.22 II-VI INCORPORATED (2021) 220
14.22.1 COMPANY SNAPSHOT 220
14.22.2 REVENUE ANALYSIS 220
14.22.3 PRODUCT PORTFOLIO 221
14.22.4 RECENT DEVELOPMENTS 221
14.22.4.1 PRODUCT LAUNCH 221
14.22.4.2 AWARDS 221
14.23 IKEDA SCIENTIFIC CO., LTD. 223
14.23.1 COMPANY SNAPSHOT 223
14.23.2 PRODUCT PORTFOLIO 223
14.23.3 RECENT DEVELOPMENT 224
14.24 MERCK KGAA (2021) 225
14.24.1 COMPANY SNAPSHOT 225
14.24.2 REVENUE ANALYSIS 225
14.24.3 PRODUCT PORTFOLIO 226
14.24.4 RECENT DEVELOPMENTS 226
14.24.4.1 COLLABORATION/ AGREEMENT 226
14.25 MILTENYI BIOTEC 228
14.25.1 COMPANY SNAPSHOT 228
14.25.2 PRODUCT PORTFOLIO 228
14.25.3 RECENT DEVELOPMENTS 229
14.25.3.1 PRODUCT LAUNCH 229
14.26 NANOCELLECT BIOMEDICAL 231
14.26.1 COMPANY SNAPSHOT 231
14.26.2 PRODUCT PORTFOLIO 231
14.26.3 RECENT DEVELOPMENTS 231
14.27 NEOGENOMICS LABORATORIES (2021) 233
14.27.1 COMPANY SNAPSHOT 233
14.27.2 REVENUE ANALYSIS 233
14.27.3 PRODUCT PORTFOLIO 234
14.27.4 RECENT DEVELOPMENT 234
14.28 NEXCELOM BIOSCIENCE LLC 235
14.28.1 COMPANY SNAPSHOT 235
14.28.2 PRODUCT PORTFOLIO 235
14.28.3 RECENT DEVELOPMENTS 235
14.29 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 237
14.29.1 COMPANY SNAPSHOT 237
14.29.2 PRODUCT PORTFOLIO 237
14.29.3 RECENT DEVELOPMENTS 237
14.30 ORFLO TECHNOLOGIES 238
14.30.1 COMPANY SNAPSHOT 238
14.30.2 PRODUCT PORTFOLIO 238
14.30.3 RECENT DEVELOPMENT 239
14.30.3.1 COLLABORATION 239
14.31 SONY BIOTECHNOLOGY INC. 240
14.31.1 COMPANY SNAPSHOT 240
14.31.2 PRODUCT PORTFOLIO 240
14.31.3 RECENT DEVELOPMENT 243
14.32 STRATEDIGM, INC 244
14.32.1 COMPANY SNAPSHOT 244
14.32.2 PRODUCT PORTFOLIO 244
14.32.3 RECENT DEVELOPMENTS 244
14.33 SYSMEX CORPORATION (2021) 245
14.33.1 COMPANY SNAPSHOT 245
14.33.2 REVENUE ANALYSIS 245
14.33.3 PRODUCT PORTFOLIO 246
14.33.4 RECENT DEVELOPMENT 246
14.33.4.1 ACQUISITION 246
14.34 UNION BIOMETRICA, INC. 247
14.34.1 COMPANY SNAPSHOT 247
14.34.2 PRODUCT PORTFOLIO 247
14.34.3 RECENT DEVELOPMENTS 247
15 QUESTIONNAIRE 249
16 RELATED REPORTS 252
Segmentation
Short Description
Asia-Pacific Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific), Industry Trends and Forecast to 2029
Market Definition:
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
Most frequently used for analyzing peripheral blood, bone marrow, and other bodily fluids, flow cytometry offers a tried-and-true approach to identifying cells in solution. Flow cytometry studies are used to define hematological malignancies and identify and count immune cells. Fluorescent probes are used in flow cytometry to identify and describe cells or particles. Applications for flow cytometry include live/dead bacterial discrimination, membrane potential, immunophenotyping, transfection efficiency, apoptosis measurement, cell cycle analysis, fluorescent intensity, cell proliferation, cell sorting, and many more. Flow cytometry has a broad range of applications for research and clinical purposes, including cancer diagnosis, chromosome identification, and protein expression.
Flow cytometry is a technology that provides rapid multi-parametric analysis of single cells in solution. They utilize lasers as a light source and produce scattered and fluorescent light signals that get detected by detectors such as photodiodes or photomultiplier tubes attached to the cytometer.
Market Segmentation:
The Asia-Pacific flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.
On the basis of product, the Asia-Pacific flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services
On the basis of technology, the Asia-Pacific flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry
On the basis of application, the Asia-Pacific flow cytometry market is segmented into research applications, clinical applications, and industrial applications
On the basis of end user, the Asia-Pacific flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others
On the basis of distribution channel, the Asia-Pacific flow cytometry market is segmented into direct tenders and retail sales
Market Players
Some of the major players operating in the Asia-Pacific flow cytometry market are:
Thermo Fisher Scientific Inc.
BD
Agilent Technologies, Inc.
Luminex Corporation (now subsidiary of DiaSorin S.p.A.)
Bio-Rad Laboratories, Inc.
Sysmex Corporation
II-VI Incorporated
Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
Cytek Biosciences
bioMrieux SA
Q2 Solutions (a Subsidiary of IQVIA)
Cytonome/ST, LLC
Merck KGaA
Sony Biotechnology Inc.
Cell Signaling Technology, Inc.
Enzo Biochem Inc.
Takara Bio Inc.
CellKraft Biotech Pvt. Ltd.
IKEDA SCIENTIFIC Co., Ltd.
Apogee Flow Systems Ltd.
Sartorius AG
Bay bioscience Co., Ltd.
Elabscience Biotechnology Inc.
Miltenyi Biotec
CytoBuoy b.v.
ORFLO Technologies
BioLegend, Inc.
NeoGenomics Laboratories
Nexcelom Bioscience LLC
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.